Reconstructive conundrums in the era of pembrolizumab treatment for breast cancer: A case series review
{{output}}
Pembrolizumab, commercially known as Keytruda, is a humanized monoclonal antibody targeting the programmed cell death protein 1 (PD-1). Its popularity increased after the KEYNOTE-522 trial demonstrated a statistically significant increase in pathologic complet... ...
